Drug Repositioning for COVID-19
Fuente:
Redalyc
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Universidad del Valle
2020
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1876449136332505088 |
|---|---|
| author | Vicente Benavides-Cordoba |
| author_facet | Vicente Benavides-Cordoba |
| contents | Drug Repositioning for COVID-19 Vicente Benavides-Cordoba Medicina 19 drug COVID pandemics drug repositioning Drug repositioning is a strategy that identifies new uses of approved drugs to treat conditions different from their original purpose. With the advance of COVID-19 and the pandemic declaration; It has become the closest alternative to reduce the advance of the virus. Antimalarial, antiviral drugs, antibiotics, glucocorticoids, monoclonal antibodies, among others, are being studied; their findings, although preliminary, could establish a starting point in the search for a solution. In this review, we present a selection of drugs, of different classes and with potential activity against COVID-19, whose trials are ongoing; and as proofs of concept, double blind, add-on event-driven, would allow proposing research that generates results in less time and preserving quality criteria for drug development and approval by regulatory agencies. 2020 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28364445007 https://www.redalyc.org/journal/283/28364445007/ https://www.redalyc.org/journal/283/28364445007/html/ https://www.redalyc.org/journal/283/28364445007/28364445007.epub https://www.redalyc.org/journal/283/28364445007/movil 10.25100/cm.v51i2.4279 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.2 Vol.51 |
| format | Artículo científico |
| id | redalyc_28364445007 |
| institution | Redalyc |
| language | en |
| publishDate | 2020 |
| publisher | Universidad del Valle |
| spellingShingle | Drug Repositioning for COVID-19 Vicente Benavides-Cordoba Medicina 19 drug COVID pandemics drug repositioning Drug Repositioning for COVID-19 Vicente Benavides-Cordoba Medicina 19 drug COVID pandemics drug repositioning Drug repositioning is a strategy that identifies new uses of approved drugs to treat conditions different from their original purpose. With the advance of COVID-19 and the pandemic declaration; It has become the closest alternative to reduce the advance of the virus. Antimalarial, antiviral drugs, antibiotics, glucocorticoids, monoclonal antibodies, among others, are being studied; their findings, although preliminary, could establish a starting point in the search for a solution. In this review, we present a selection of drugs, of different classes and with potential activity against COVID-19, whose trials are ongoing; and as proofs of concept, double blind, add-on event-driven, would allow proposing research that generates results in less time and preserving quality criteria for drug development and approval by regulatory agencies. 2020 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28364445007 https://www.redalyc.org/journal/283/28364445007/ https://www.redalyc.org/journal/283/28364445007/html/ https://www.redalyc.org/journal/283/28364445007/28364445007.epub https://www.redalyc.org/journal/283/28364445007/movil 10.25100/cm.v51i2.4279 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.2 Vol.51 |
| title | Drug Repositioning for COVID-19 |
| topic | Medicina 19 drug COVID pandemics drug repositioning |
| url | https://www.redalyc.org/articulo.oa?id=28364445007 https://www.redalyc.org/journal/283/28364445007/ https://www.redalyc.org/journal/283/28364445007/html/ https://www.redalyc.org/journal/283/28364445007/28364445007.epub https://www.redalyc.org/journal/283/28364445007/movil |